We are live on ! Find out more
RMD icon

ResMed
RMD

723 hedge funds and large institutions have $24.6B invested in ResMed in 2021 Q4 according to their latest regulatory filings, with 110 funds opening new positions, 238 increasing their positions, 257 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 110 | Existing positions closed: 62

5% more funds holding

Funds holding: 686 → 723 (+37)

3% less capital invested

Capital invested by funds: $25.4B → $24.6B (-$783M)

7% less repeat investments, than reductions

Existing positions increased: 238 | Existing positions reduced: 257

1.21% less ownership

Funds ownership: 66.17% → 64.96% (-1.2%)

17% less funds holding in top 10

Funds holding in top 10: 12 → 10 (-2)

35% less call options, than puts

Call options by funds: $41.5M | Put options by funds: $64.2M

Holders
723
Holders Change
+37
Holders Change %
+5.39%
% of All Funds
11.13%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.15%
New
110
Increased
238
Reduced
257
Closed
62
Calls
$41.5M
Puts
$64.2M
Net Calls
-$22.7M
Net Calls Change
-$28.2M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$93.5M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$79M
3
AAM
Ardevora Asset Management
United Kingdom
+$76.5M
4
State Street
State Street
Massachusetts
+$66.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$51.6M

Top Sellers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$715M
2
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking
Japan
-$51.2M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$48M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$41.2M
5
WT
Washington Trust
Rhode Island
-$36.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
701
Schubert & Co
Texas
$3K +$3.37K +13 New
MCM
702
Manchester Capital Management
Vermont
$2K -$519 -2 -25%
CCC
703
Crescent Capital Consulting
Louisiana
$2K – – –
PWMG
704
Prestige Wealth Management Group
New Jersey
$2K – – –
SC
705
Sierra Capital
Florida
$2K +$1.56K +6 New
TF
706
Tompkins Financial
New York
$2K +$2.33K +9 New
AHIA
707
Andrew Hill Investment Advisors
Florida
$2K +$2.6K +10 New
MGIM
708
M&G Investment Management
United Kingdom
$1.41K -$8.33M -32,085 -86%
GEA
709
Glen Eagle Advisors
New Jersey
$1.3K – – –
AWM
710
Avior Wealth Management
Nebraska
$1K -$519 -2 -33%
CCM
711
Covington Capital Management
California
$1K – – –
GWM
712
Geneos Wealth Management
Colorado
$1K – – –
SWA
713
SOA Wealth Advisors
New York
$1K – – –
SCA
714
Stonebridge Capital Advisors
Minnesota
$1K – – –
TFM
715
TFC Financial Management
Massachusetts
$1K – – –
CSWM
716
Cassady Schiller Wealth Management
Ohio
$1K +$519 +2 New
AA
717
Addison Advisors
Vermont
$1K +$778 +3 New
CAC
718
Core Alternative Capital
Georgia
$1K +$1.3K +5 New
WA
719
WestEnd Advisors
North Carolina
$260 +$259 +1 New
WIM
720
Westside Investment Management
California
$57 – – –
BBHC
721
Brown Brothers Harriman & Co
New York
$10 -$29.6K -114 -74%
WT
722
Washington Trust
Rhode Island
– -$36.3M -137,569 Closed
ACI
723
AMP Capital Investors
Australia
– -$19.9M -75,621 Closed
SAM
724
Sectoral Asset Management
Quebec, Canada
– -$15.8M -60,105 Closed
AIM
725
Achmea Investment Management
Netherlands
– -$15.1M -57,329 Closed
27 28
29
30 31

RMD Hedge Fund Activity: Q4 2021 in Review

723 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2021, worth a combined $24.6B — down 3.1% from $25.4B a quarter earlier.

Buyers outnumbered sellers: 110 funds opened new RMD positions and 62 closed out — a net gain of 48 holders — while 238 added to existing stakes and 257 trimmed.

The largest buyer was BlackRock, adding an estimated $93.5M. The largest seller was Baillie Gifford & Co, cutting an estimated $715M.

  • 723 institutional investors held ResMed (RMD) as of Q4 2021, up from 686 in Q3 2021.
  • Funds reported $24.6B of ResMed stock for Q4 2021, down 3.1% quarter-over-quarter.
  • 110 funds opened new ResMed positions in Q4 2021 and 62 closed out, a net change of +48 holders.
  • The largest ResMed buyer in Q4 2021 was BlackRock, an estimated $93.5M added.
  • The largest ResMed seller in Q4 2021 was Baillie Gifford & Co, an estimated $715M sold.

Based on aggregated 13F filings for Q4 2021.